|
Volumn 9, Issue 4, 2014, Pages 812-814
|
Dialysis therapies: A national dialogue
|
Author keywords
[No Author keywords available]
|
Indexed keywords
UREMIC TOXIN;
ARTICLE;
CARDIOVASCULAR RISK;
COGNITIVE THERAPY;
COMPARATIVE EFFECTIVENESS;
DIALYSATE;
END STAGE RENAL DISEASE;
HEALTH CARE QUALITY;
HEALTH PROGRAM;
HEMODIALYSIS;
HEMODYNAMIC MONITORING;
HOME DIALYSIS;
HUMAN;
KIDNEY FUNCTION;
KIDNEY RESEARCH NATIONAL DIALOGUE;
MEDICAL RESEARCH;
OUTCOME ASSESSMENT;
PATIENT CARE;
PATIENT DECISION MAKING;
QUALITY OF LIFE;
TOTAL QUALITY MANAGEMENT;
VASCULAR ACCESS;
KIDNEY FAILURE, CHRONIC;
MORTALITY;
PATIENT SELECTION;
RENAL REPLACEMENT THERAPY;
RISK FACTOR;
TREATMENT OUTCOME;
HUMANS;
KIDNEY FAILURE, CHRONIC;
PATIENT SELECTION;
PATIENT-CENTERED CARE;
QUALITY IMPROVEMENT;
QUALITY INDICATORS, HEALTH CARE;
QUALITY OF LIFE;
RENAL DIALYSIS;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 84903219796
PISSN: 15559041
EISSN: 1555905X
Source Type: Journal
DOI: 10.2215/CJN.12601213 Document Type: Article |
Times cited : (12)
|
References (3)
|